clinical pathology quality dashboard april 2010. clinical pathology quality dashboard inpatient...
TRANSCRIPT
Clinical PathologyQuality Dashboard
April 2010
Clinical Pathology Quality Dashboard
Inpatient Phlebotomy First AM Blood Draws
Clinical Pathology Quality Dashboard
Inpatient Phlebotomy First AM Blood Test Results:
PT/PTT, CBCP, and Comprehensive Panel
Inpatient Phlebotomy Draws
Clinical Pathology Quality Dashboard
Clinical Pathology Quality Dashboard
Turnaround Times
Clinical Pathology Quality Dashboard
Specimen Processing Turnaround TimeAverage Daily Turnaround Time + 1 standard deviation
for Inpatient Specimens going to Chemistry
September 2006 - July 2007
0:00
0:14
0:28
0:43
0:57
1:12
Sep-06 Oct-06 Nov-06 Dec-06 Jan-07 Feb-07 Mar-07 Apr-07 May-07 Jun-07
Tu
rnar
ou
nd
Tim
e in
Min
ute
s
Clinical Pathology Quality Dashboard
Molecular Diagnostics Laboratory
0
1
2
3
4
5
6
7
8
9
10
0
200
400
600
800
1000
1200
1400
January 2002
July 2002
January 2003
July 2003
January 2004
July 2004
January 2005
July 2005
January 2006
July 2006
January 2007
July 2007
January 2008
July 2008
January 2009
July 2009
January 2010
TAT
(day
s)
Spe
cim
ens
Rec
eive
d pe
r M
onth
Month/Year
Specimens Received and Turnaround TimeJanuary 2002 - March 2010
# Specimens TAT Linear (# Specimens) Linear (TAT)
Shift in client testing
Clinical Pathology Quality Dashboard
Chemistry In-Lab Turnaround Times
0
5
10
15
20
25
30
Per
cen
tag
e
Oct 07 - Mar 2010
Sample Turn-Around Time
Routine > 60 min stat > 45 min inpt stat > 45 min outp stat
UMHS Blood Product Utilization
Clinical Pathology Quality Dashboard
Clinical Pathology Quality Dashboard
CAP Proficiency Testing
3rd Quarter FY 2010
Clinical Pathology 53 = Number of Challenges 100% = Satisfactory ResultsAnatomic Pathology 0 = Number of Challenges N/A = Satisfactory ResultsDepartment Total 53 = Number of Challenges 100% = Satisfactory Results
9799.5 99 100
92
9998
100
50
60
70
80
90
100
0
100
200
300
400
500
600
4th Qtr 1st Qtr 2nd Qtr 3rd Qtr 4th Qtr 1st Qtr 2nd Qtr 3rd Qtr
Per
cen
t S
atis
fact
ory
Nu
mb
er o
f C
hal
len
ges
Clinical Pathology Scores
FY2008 FY2009 FY2010
Clinical Pathology Quality Dashboard
CP Financial Measures
*excludes Blood Bank and Phlebotomy
Clinical Laboratory Operations Initiatives
• Immunopathology Laboratory has nearly
completed clinical laboratory validation of a new Graft-versus-Host Disease predication panel (elafin, IL-2Rα, TNFR1). This panel was developed by Drs. Sophie Paczesny, James Ferrara, and colleagues from the Universities of Michigan and Washington.
• Effective June 7, 2010, the Michigan
Medical Genetics Laboratory will offer inhouse cystic fibrosis diagnostic mutation testing (60 mutations). This testing will complement prenatal CF mutation screening currently offered by the Molecular Diagnostics Laboratory.
Clinical Laboratory Service Enhancements
• The Clinical Laboratories have developed a Pending “Overdue” Test Result monitoring system that encompasses all workcenters. This system will improve the robustness of laboratory testing.
Kudos
• Congratulations and thank you to all Clinical Laboratory personnel, supervisors, and chief technologists for successful completion of our biannual CAP self-inspection.